LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/ATEC to Acquire EOS imaging for Nearly $122 Million
Company News

ATEC to Acquire EOS imaging for Nearly $122 Million

April 2, 2020 2 min read Premium comments

Advertisement

ATEC to Acquire EOS imaging for Nearly $122 Million
Courtesy of Alphatec Holdings, Inc. (ATEC) and EOS imaging, SA
#alphatecholdingsSecondary#eosimaging#3dimaging#medicalimaging#skeletalimaging

Spinal implant manufacturer Alphatec Holdings, Inc. (ATEC) has entered into an agreement to acquire EOS imaging, SA, for a purchase price of up to $88 million, plus $33.9 million retirement of debt, in a combination of cash and equity. The transaction is expected to close in the third quarter of 2020.

EOS imaging is an orthopedic medical imaging company based in Paris, France. EOS systems are full body skeletal imaging systems able to generate 3D images and data. EOS imaging has gone through a period of expansion since becoming a publicly traded company on Euronext Paris (EOSI) in 2012. EOS systems are now available in 51 countries including the United States, Japan, and China.

EOS imaging Chief Executive Officer Mike Lobinsky commented on the acquisition, “We are very enthusiastic about the opportunity to join the complementary strengths and know-how of EOS imaging and ATEC.”

Lobinsky continued, “I have no doubt that our organizations will be able to quickly create a highly differentiated end-to-end offering that will accelerate growth in the U.S. in the short term, while we continue to expand internationally, paving the way for the future global growth of the combined entity.”

Based in Carlsbad, California, Alphatec Holdings, Inc. is a medical technology company focused on spinal fusion. Through its subsidiary, Alphatec Spine, Inc., it creates products for the surgical treatment of spine disorders.

ATEC Chairman and Chief Executive Officer Pat Miles said of the acquisition, “This is a monumental transaction for ATEC.” Miles continued, “While spine’s large players are investing in enabling technologies, we are thinking differently. We created a conduit to deliver information into the operating room with AlphaInformatiX. This transaction will integrate spine imaging and anatomical modeling onto the platform to actually inform the operative experience. By pairing ATEC’s approach-based solutions with imaging founded on Nobel Prize-winning technology, we expect to significantly increase demand for ATEC hardware and EOS systems and create a formidable competitive advantage.”

The transaction will take place through ATEC’s tender offer for all of the issued and outstanding shares and convertible notes of EOS imaging for a price of EUR 2.80 per EOS share, or an exchange tender offer where each EOS shareholder will receive 0.50 ATEC common shares per EOS share. The Boards of Directors of both ATEC and EOS have approved the offer.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy